Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1999
08/05/1999CA2319698A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
08/05/1999CA2319669A1 Mutant herpes simplex viruses and uses thereof
08/05/1999CA2319514A1 Spray drying of pharmaceutical formulations containing amino acid-based materials
08/05/1999CA2319306A1 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
08/05/1999CA2319195A1 Method of regulating glucose metabolism, and reagents related thereto
08/05/1999CA2319144A1 Recombinant proteins from hgf and msp
08/05/1999CA2319143A1 Modulation of sodium channels in dorsal root ganglia
08/05/1999CA2319129A1 67 human secreted proteins
08/05/1999CA2319117A1 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999CA2319081A1 Human cystatin f
08/05/1999CA2318744A1 Genetic immunization with nonstructural proteins of hepatitis c virus
08/05/1999CA2318513A1 Process for making absorbable microparticles
08/05/1999CA2318152A1 Absorbable microparticles
08/05/1999CA2317814A1 Human protein kinase molecules
08/05/1999CA2316223A1 Hydrophilic coating for an intracorporeal medical device
08/04/1999EP0933425A1 Semaphorin family polypeptides and polynucleotides
08/04/1999EP0933424A1 Novel proteins c16 and c16n or genes encoding the same
08/04/1999EP0933423A1 Meltrins
08/04/1999EP0933422A1 Cyclic lipopeptide acylase
08/04/1999EP0933380A1 Method of searching for physiologically active substances and process for producing the same
08/04/1999EP0933379A1 Novel peptide derivatives having thiazolyl-alanine residue
08/04/1999EP0933365A2 Growth hormone secretagogues
08/04/1999EP0933083A1 Process for the purification of serum albumin
08/04/1999EP0933082A1 Methods of manipulation of cell differentiation
08/04/1999EP0932698A1 Oligonucleotide treatments and compositions for human melanoma
08/04/1999EP0932689A1 Homocysteine desulphurase from the protozoan trichomonas vaginalis
08/04/1999EP0932687A1 Novel human phosphorylase kinase gamma subunit
08/04/1999EP0932686A2 Telomerase reverse transcriptase
08/04/1999EP0932681A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/04/1999EP0932680A2 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis
08/04/1999EP0932679A1 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-$g(a) NUCLEIC ACIDS
08/04/1999EP0932678A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
08/04/1999EP0932675A2 Epidermal differentiation factor
08/04/1999EP0932674A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES
08/04/1999EP0932672A1 Human sulfonylurea receptor surh
08/04/1999EP0932671A2 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein
08/04/1999EP0932668A1 Two human cathepsin proteins
08/04/1999EP0932666A1 Map kinases: polypeptides, polynucleotides and uses thereof
08/04/1999EP0932626A1 G protein-coupled receptor antagonists
08/04/1999EP0932624A1 Pharmaceutical and diagnostic use of serum amyloid p component
08/04/1999EP0932623A1 Colostrinin, and uses thereof
08/04/1999EP0932621A1 An immunogenic determinant for use in the diagnosis of kaposi's sarcoma
08/04/1999EP0932620A1 Antimicrobial peptide analogs of gramicidin s and compositions comprising them
08/04/1999EP0932619A1 Macrocyclic peptides useful in the treatment of thrombin related disorders
08/04/1999EP0932618A1 Peptide analogues containing a 7-membered lactam ring
08/04/1999EP0932617A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
08/04/1999EP0932615A1 SELECTIVE FACTOR Xa INHIBITORS
08/04/1999EP0932614A1 Peptide prodrugs containing an alpha-hydroxyacid linker
08/04/1999EP0932613A1 BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
08/04/1999EP0932608A1 SELECTIVE FACTOR Xa INHIBITORS
08/04/1999EP0932606A1 Inhibitors of prenyl transferases
08/04/1999EP0932598A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
08/04/1999EP0932420A1 Drug delivery using terminal complement components
08/04/1999EP0932418A2 Method for recombinant adeno-associated virus-directed gene therapy
08/04/1999EP0932417A1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
08/04/1999EP0932415A1 Method of preventing acute rejection following solid organ transplantation
08/04/1999EP0932414A1 USES OF COMPOSITIONS WITH alpha-LACTALBUMEN BASE
08/04/1999EP0932413A1 Method for treatment of immunodeficiency virus infection
08/04/1999EP0932412A1 Antiviral treatment
08/04/1999EP0932411A1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
08/04/1999EP0932390A1 Therapeutic liposome composition and method
08/04/1999EP0871644A4 Platelet-endothelial cell adhesion molecule-1 compositions and methods
08/04/1999EP0760601A4 Predicting fetal membrane rupture by mmp-9 activity
08/04/1999EP0755942B1 N-amidino dermorphin derivative
08/04/1999EP0744957B1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/04/1999EP0695309B1 Oxytocin antagonist
08/04/1999EP0692970B1 Use of actin-binding compounds for the manufacture of a medicament for reducing the viscosity of pathological mucoid airway contents in the respiratory tract
08/04/1999EP0665739B1 Morphogen-induced periodontal tissue regeneration
08/04/1999EP0640086B1 MERCAPTOACETYLAMIDO PYRIDAZO[ 1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
08/04/1999EP0585242B1 Wound healing
08/04/1999EP0575490B1 GnRH ANALOGS
08/04/1999EP0567585B1 Hepatic growth factor receptor is the met proto-oncogene
08/04/1999EP0365657B1 Dna encoding androgen receptor protein
08/04/1999CN1225131A Method for treating amyotrophic lateral sclerosis
08/04/1999CN1225129A Chimeric heteromultimer adhesins
08/04/1999CN1225019A Inhibition of Ii synthesis
08/04/1999CN1225016A Interleukin-8 as an antiviral and antitumor agent
08/04/1999CN1225015A APL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies
08/04/1999CN1224718A Thiazole derivatives
08/04/1999CN1044479C Process for preparation of anti-thrombin polypeptides
08/04/1999CA2256942A1 Human growth hormone-containing aqueous pharmaceutical composition
08/03/1999US5932779 Transgenic mouse with mutation in endogenous melanocortin-4-receptor gene; obesity, anorexia, and cachexia treatment
08/03/1999US5932737 Peptide compounds for treatment of no-mediated diseases
08/03/1999US5932733 Inhibitor of thrombin
08/03/1999US5932716 Disclosed herein are methods and compositions for identifying morphogen analogs.
08/03/1999US5932712 Annexin binding protein
08/03/1999US5932706 Antibodies specific for a haemostatic protein their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
08/03/1999US5932705 Pasteurella haemolytica culturing to produce secreted polypeptides, fractionating peptides by molecular weight, identifying and purifying antigen
08/03/1999US5932703 The present invention provides purified and isolated polynucleotide sequences encoding a novel human macrophage-derived c--c chemokine designated mdc, and polypeptide analogs thereof.
08/03/1999US5932702 Human G-protein coupled receptor
08/03/1999US5932701 ribA
08/03/1999US5932700 Efficient antitumor agent; diagnostic tool for detection of uterine tumors
08/03/1999US5932694 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
08/03/1999US5932693 The present invention relates to novel antithrombotic peptides and, more particularly, to short peptides that mediate divalent cation-independent adhesion of platelets to fibronectin.
08/03/1999US5932621 Methods of using ajoene for the treatment of tumors
08/03/1999US5932606 Pyrazinone, pyridinone, piperidine and pyrrolidine thrombin inhibitors
08/03/1999US5932567 Thrombin inhibitors
08/03/1999US5932560 Treatment of conditions and disease
08/03/1999US5932557 Adenosine A1 receptor antisense oligonucleotide treatment of alcohol and marijuana-induced psychomotor impairments
08/03/1999US5932556 Using an oligonucleotide